Irohigh 100 Injection 5 ml belongs to the class of 'haematinics,' primarily used to treat iron deficiency anaemia. It is useful to treat anaemia in patients with long-term kidney diseases. Iron deficiency anaemia is a condition in which the body does not have enough red blood cells to carry adequate oxygen required to various body tissues due to insufficient iron.
Irohigh 100 Injection 5 ml contains Iron (III) isomaltoside 1000/Ferric derisomaltose, an iron replacement product required by the red blood cells to carry oxygen to other body cells and tissues. Iron isomaltoside is a compound that releases iron, which binds to transferrin, a transport protein. The transferrin takes the iron to erythroid precursor cells (cells that develop into mature red blood cells) for incorporation into the haemoglobin molecule.
Your doctor will decide the dosage and duration based on your medical condition. In some cases, it may cause side effects like nausea, rash, pain and swelling at the injection site. Most of these side effects of Irohigh 100 Injection 5 ml do not require medical attention and gradually resolve over time. However, if these side effects persist longer, please consult your doctor.
Brief your medical history to the doctor if you have any heart, liver or kidney diseases, iron overload disorders like hemochromatosis, immune system disorders (lupus), low blood pressure, rheumatoid arthritis, asthma, and eczema before starting Irohigh 100 Injection 5 ml. Pregnant and breastfeeding women should consult the doctor before starting Irohigh 100 Injection 5 ml. Irohigh 100 Injection 5 ml is not recommended in children and adolescents below 18 years of age.